SLC7A11 and hepatocellular carcinoma: Importantly, our results indicated that Exo-SR was able to rescue the decrease in SLC7A11 expression induced by sorafenib, whereas interfering with SLC7A11 expression in HCC cells eliminated the suppressive effect of Exo-SR on ferroptosis.